{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:47:58Z","timestamp":1791582478004,"version":"4.3.4"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Type 2 diabetes mellitus (DM) is a known risk factor for sarcopenia. Apolipoprotein J (ApoJ) and myostatin (MSTN) have been implicated in muscle glucose metabolism. We aimed to examine the association between serum ApoJ and MSTN levels and sarcopenia in older adults, with and without DM.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This cross-sectional study included 130 community-dwelling adults aged 65\u201392 years. Serum ApoJ and MSTN levels were measured using ELISA. Sarcopenia was defined as low appendicular skeletal muscle index (ASMI) with low handgrip strength (HS) and\/or poor physical performance (PP). Associations were analyzed using age- and sex-adjusted models and logistic regression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Sarcopenia was present in 17.7% of participants. Those with sarcopenia had higher ApoJ levels than those without (p = 0.022). ApoJ levels did not differ by DM status, but MSTN levels were lower in participants with DM (p = 0.012). MSTN levels were positively associated with ASMI, HS, and PP. In logistic regression, ApoJ was independently associated with sarcopenia (OR = 1.027, p = 0.006) and severe sarcopenia (OR = 1.041, p = 0.027), while MSTN was inversely associated with severe sarcopenia (OR = 0.980, p = 0.025). The highest sarcopenia prevalence (26.7%) was observed in the high ApoJ\/low MSTN group, and the lowest (0%) in the low ApoJ\/high MSTN group.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Elevated ApoJ and reduced MSTN levels are associated with sarcopenia in older adults. These biomarkers may play opposing roles and serve as potential predictors for sarcopenia.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1592112","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T04:10:38Z","timestamp":1751256638000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Associations of circulating apolipoprotein J and myostatin with sarcopenia in older adults with and without type 2 diabetes: a cross-sectional study"],"prefix":"10.3389","volume":"16","author":[{"given":"Inha","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Hye","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Joo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Young","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hee","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Bum","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji A","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169548","article-title":"Health outcomes of sarcopenia: a systematic review and meta-analysis","volume":"12","author":"Beaudart","year":"2017","journal-title":"PloS One"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31138-9","article-title":"Sarcopenia","volume":"393","author":"Cruz-Jentoft","year":"2019","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/jcsm.12783","article-title":"Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis","volume":"13","author":"Petermann-Rocha","year":"2022","journal-title":"J cachexia sarcopenia Muscle"},{"key":"B4","doi-asserted-by":"publisher","first-page":"155533","DOI":"10.1016\/j.metabol.2023.155533","article-title":"Epidemiology of sarcopenia: Prevalence, risk factors, and consequences","volume":"144","author":"Yuan","year":"2023","journal-title":"Metabolism"},{"key":"B5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"B6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jamda.2019.12.012","article-title":"Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment","volume":"21","author":"Chen","year":"2020","journal-title":"J Am Med Directors Assoc"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-2310","article-title":"Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: the Korean Sarcopenic Obesity Study (KSOS)","volume":"33","author":"Kim","year":"2010","journal-title":"Diabetes Care"},{"key":"B8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/nu13010183","article-title":"A narrative review on sarcopenia in type 2 diabetes mellitus: prevalence and associated factors","volume":"13","author":"Izzo","year":"2021","journal-title":"Nutrients"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1109800","article-title":"A bi-directional Mendelian randomization study of sarcopenia-related traits and type 2 diabetes mellitus","volume":"14","author":"Chen","year":"2023","journal-title":"Front Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s12877-023-04104-9","article-title":"Possible sarcopenia and risk of new-onset type 2 diabetes mellitus in older adults in China: A 7-year longitudinal cohort study","volume":"23","author":"Luo","year":"2023","journal-title":"BMC geriatrics"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S186600","article-title":"Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship","volume":"12","author":"Mesinovic","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B12","doi-asserted-by":"publisher","first-page":"719","DOI":"10.4093\/dmj.2023.0112","article-title":"Type 2 diabetes mellitus and sarcopenia as comorbid chronic diseases in older adults: established and emerging treatments and therapies","volume":"47","author":"Mesinovic","year":"2023","journal-title":"Diabetes Metab J"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2016.04.019","article-title":"Skeletal muscle regulates metabolism via interorgan crosstalk: roles in health and disease","volume":"17","author":"Argil\u00e9s","year":"2016","journal-title":"J Am Med Directors Assoc"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exger.2016.09.007","article-title":"Biomarkers in sarcopenia: a multifactorial approach","volume":"85","author":"Curcio","year":"2016","journal-title":"Exp gerontology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-4927-9","article-title":"Myokines in metabolic homeostasis and diabetes","volume":"62","author":"Eckel","year":"2019","journal-title":"Diabetologia"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-822146-4.00006-5","article-title":"Myokines: A potential key factor in development, treatment, and biomarker of sarcopenia","volume-title":"Sarcopenia","author":"Aoi","year":"2021"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2017.09.014","article-title":"Circulating ApoJ is closely associated with insulin resistance in human subjects","volume":"78","author":"Seo","year":"2018","journal-title":"Metabolism"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1038\/s41467-020-15963-w","article-title":"Apolipoprotein J is a hepatokine regulating muscle glucose metabolism and insulin sensitivity","volume":"11","author":"Seo","year":"2020","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0065-230X(09)04009-3","article-title":"Oxidative stress in Malignant progression: the role of clusterin, a sensitive cellular biosensor of free radicals","volume":"104","author":"Trougakos","year":"2009","journal-title":"Adv Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-019-1868-5","article-title":"Clusterin silencing restores myoblasts viability and down modulates the inflammatory process in osteoporotic disease","volume":"17","author":"Pucci","year":"2019","journal-title":"J Trans Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/387083a0","article-title":"Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member","volume":"387","author":"McPherron","year":"1997","journal-title":"Nature"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148372","article-title":"Targeting the myostatin signaling pathway to treat muscle loss and metabolic dysfunction","volume":"131","author":"Lee","year":"2021","journal-title":"J Clin Invest"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1181913","article-title":"Myostatin: a potential therapeutic target for metabolic syndrome","volume":"14","author":"Yang","year":"2023","journal-title":"Front Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.785712","article-title":"Regulation of myostatin on the growth and development of skeletal muscle","volume":"9","author":"Chen","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s11010-024-05120-y","article-title":"Therapeutic applications and challenges in myostatin inhibition for enhanced skeletal muscle mass and functions","volume":"480","author":"Wetzlich","year":"2025","journal-title":"Mol Cell Biochem"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/SPC.0000000000000013","article-title":"Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders","volume":"7","author":"Smith","year":"2013","journal-title":"Curr Opin supportive palliative Care"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.3390\/cells9122657","article-title":"The failed clinical story of myostatin inhibitors against Duchenne muscular dystrophy: exploring the biology behind the battle","volume":"9","author":"Rybalka","year":"2020","journal-title":"Cells"},{"key":"B28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1177\/1757975919854301","article-title":"Development of the Korean Global Physical Activity Questionnaire: reliability and validity study","volume":"27","author":"Lee","year":"2020","journal-title":"Global Health promotion"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1079\/NRR200370","article-title":"Food-frequency questionnaires: a review of their design, validation and utilisation","volume":"17","author":"Cade","year":"2004","journal-title":"Nutr Res Rev"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"diabetologia"},{"key":"B31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.mce.2008.12.019","article-title":"Measurement of myostatin concentrations in human serum: circulating concentrations in young and older men and effects of testosterone administration","volume":"302","author":"Lakshman","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4235\/agmr.23.0009","article-title":"Korean Working Group on Sarcopenia guideline: expert consensus on sarcopenia screening and diagnosis by the Korean Society of Sarcopenia, the Korean Society for Bone and Mineral Research, and the Korean Geriatrics Society","volume":"27","author":"Baek","year":"2023","journal-title":"Ann geriatric Med Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/geronj\/49.2.M85","article-title":"A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission","volume":"49","author":"Guralnik","year":"1994","journal-title":"J gerontology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.v67.12","article-title":"Validation of a multi\u2013sensor-based kiosk for Short Physical Performance Battery","volume":"67","author":"Jung","year":"2019","journal-title":"J Am Geriatrics Soc"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab884","article-title":"Prevalence and risk factors of sarcopenia in patients with diabetes: a meta-analysis","volume":"107","author":"Feng","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2018.0160","article-title":"Combined aerobic and resistance exercise training reduces circulating apolipoprotein J levels and improves insulin resistance in postmenopausal diabetic women","volume":"44","author":"Jeon","year":"2020","journal-title":"Diabetes Metab J"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/k3vtg5","article-title":"Clusterin is upregulated in serum and muscle tissue in idiopathic inflammatory myopathies and associates with clinical disease activity and cytokine profile","volume":"39","author":"Krop\u00e1\u010dkov\u00e1","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1182\/blood.V96.2.398","article-title":"Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas","volume":"96","author":"Wellmann","year":"2000","journal-title":"Blood J Am Soc Hematol"},{"key":"B39","article-title":"Coordinately up-regulated genes in ovarian cancer","volume":"61","author":"Hough","year":"2001","journal-title":"Cancer Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3858\/emm.2011.43.1.006","article-title":"Clusterin protects H9c2 cardiomyocytes from oxidative stress-induced apoptosis via Akt\/GSK-3\u03b2 signaling pathway","volume":"43","author":"Jun","year":"2011","journal-title":"Exp Mol Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.151270098","article-title":"Regulation of myostatin activity and muscle growth","volume":"98","author":"Lee","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25268","article-title":"Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: results of a randomized, placebo-controlled clinical trial","volume":"55","author":"Campbell","year":"2017","journal-title":"Muscle Nerve"},{"key":"B43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1093\/ndt\/gfz210","article-title":"Muscle mass and plasma myostatin after exercise training: a substudy of Renal Exercise (RENEXC)\u2014a randomized controlled trial","volume":"36","author":"Zhou","year":"2021","journal-title":"Nephrol Dialysis Transplant"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0604893104","article-title":"Lack of myostatin results in excessive muscle growth but impaired force generation","volume":"104","author":"Amthor","year":"2007","journal-title":"Proc Natl Acad Sci"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1592112\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T04:10:39Z","timestamp":1751256639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1592112\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":44,"alternative-id":["10.3389\/fendo.2025.1592112"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1592112","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"article-number":"1592112"}}